Evidation
PrivateLast Round
Series E
Mar 22, 2021
Est. Valuation
$1B
Total Funding Raised
$259.2M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Evidation is a health technology company that provides a data analytics platform to collect and analyze continuous behavior data and healthcare information for improved health insights and outcomes.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Healthcare Analytics, Patient Engagement, Data Integration
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Evidation Comparables
Compare Evidation with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Truveta | 79% | |
| Koneksa Health | 79% | |
| PicnicHealth | 78% |
Evidation Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series E | Mar 22, 2021 | ||||
| Series D | Jul 1, 2020 | ||||
| Series C | Aug 1, 2018 | ||||
| Series B Extension | Apr 27, 2017 | ||||
| Series B | Oct 11, 2016 | ||||
Series A | Jan 1, 2015 |
Key People
Founding team and executive leadership
Evidation Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| S32 | Series D |
| Rock Health | Series A |
| Fresco Capital | Series B |
| OMERS | Series E |
| SV Health Investors | Series D, Series C |
| A. M. Pappas & Associates | Series B |
| Kaiser Permanente Ventures | Series E |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 7, 2026
Added Jazz Pharmaceuticals, Inc. from the Pharmaceuticals industry.
- May 7, 2026
Added Genentech, a biotechnology/pharmaceuticals company, as a customer.
Evidation Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Evidation's valuation, stock price, and market status.
Is Evidation a public or private company?
Evidation is a private company.
What is the current stock price of Evidation?
Evidation is a private company with no public stock price. No recent secondary market data is available.
How much is Evidation worth (valuation)?
Evidation's valuation is estimated at $1.0B based on funding round data.
Can I buy Evidation stock?
Evidation shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Evidation's last funding round?
Evidation's most recent funding round was Series E on March 22, 2021.
Who are the main investors in Evidation?
Key investors in Evidation include OMERS, SV Health Investors, B Capital Group, OMERS Growth Equity, General Electric Ventures.
Will Evidation IPO soon?
No public IPO plans have been announced for Evidation.
How can I track Evidation secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Evidation's secondary market activity and sign up for updates.